The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria

Vox Sanguinis

Volumn 88, Issue 2, 2005, Pages 98-106

  Seed, Clive R ^a,d   Cheng, A ^a   Davis, T M E ^b   Bolton, W V ^a   Keller, A J ^a   Kitchen, A ^c   Cobain, T J ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d NONE   (Australia)

Author keywords

Blood donor; Falciparum; Malaria; Screening; Transfusion

Indexed keywords

PROTOZOON ANTIBODY; RECOMBINANT ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC KIT; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRAVEL;

ALGORITHMS; ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD DONORS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALARIA; MASS SCREENING; PLASMODIUM FALCIPARUM; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 14944339419     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00605.x     Document Type: Article

References (26)

1. Chiodini PL, Hartley S, Hewitt PE, Barbara JA, Lalloo K, Bligh J, Voller A: Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang 1997; 73:143-148
2. Mungai M, Tegtmeier G, Chamberland M, Parise M: Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344:1973-1978
3. Whyte GS: Therapeutic goods and malaria. Med J Aust 1992; 157:439-440
4. Brasseur P, Bonneau JC: [Transfusion-induced malaria: risks, prevention and cost (1 year's experience).] Rev Fr Transfus Immunohematol 1981; 24:597-608
5. Davidson N, Woodfield G, Henry S: Malarial antibodies in Auckland blood donors. N Z Med J 1999; 112:181-183
6. Silvie O, Thellier M, Rosenheim M, Daity A, Lavigne P, Danis M, Mazier D: Potential value of Plasmodium falciparum-associated antigen and antibody detection for screening of blood donors to prevent transfusion-transmitted malaria. Transfusion 2002; 42:357-362
7. Hassig A, Ambroise-Thomas P, Bruce-Chwatt L, Emmanuel J, Masvre R, Perrin L, Soulier JP: Which are the appropriate modifications of existing regulations designed to prevent the transmission of malaria by blood transfusion, in view of the increasing frequency of travel to endemic areas? Vox Sang 1987; 52:138-148
8. Contreras CE, Pance A, Marcano N, Gonzalez N, Bianco N: Detection of specific antibodies to Plasmodium falciparum in blood bank donors from malaria-endemic and non-endemic areas of Venezuela. Am J Trop Med Hyg 1999; 60:948-953
9. Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, Jeon BH, Koh JS, Han JH, Lee SJ, Park JW, Kaslow DC, Strickman D, Roh CS: Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 2000; 62:720-725
10. Mertens G, Vervoort T, Heylen S, Muylle L: Malaria antibody ELISA insufficiently sensitive for blood donor screening. Vox Sang 1999; 77:237-238
11. Gillon J: Introduction of malaria antibody ELISA. Vox Sang 1998; 75:80-81
12. Williams HA, Roberts J, Kachur SP, Barber AM, Barat LM, Bloland PB, Ruebush TK, 2nd, Wolfe EB: Malaria surveillance - United States, 1995. MMWR CDC Surveill Summ 1999; 48:1-23
13. Bradley D, Warhurst D, Blaze M, Smith V: Malaria imported into the United Kingdom in 1992 and 1993. Commun Dis Rep CDR Rev 1994; 4:R169-R172
14. Charles D, Hart J, Davis WA, Sullivan E, Dowse GK, Davis TME: Notifications of imported malaria in Western Australia 1990-2001. Incidence, associated factors and chemoprophylaxis. Med J Aust 2005; in press
15. Newcombe RG: Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-872
16. MMWR: Probable transfusion-transmitted malaria - Houston Texas 2003. MMWR 2004; 52:1075-1076
17. de Silva M, Contreras M, Barbara J: Two cases of transfusion-transmitted malaria (TTM) in the UK. Transfusion 1988; 28:86
18. Ramasamy R: Molecular basis for evasion of host immunity and pathogenesis in malaria. Biochim Biophys Acta 1998; 1406:10-27
19. Draper CC, Sirr SS: Serological investigations in retrospective diagnosis of malaria. Br Med J 1980; 280:1575-1576
20. Bruce-Chwatt LJ, Dodge JS, Draper CC, Topley E, Voller A: Sero-epidemiological studies on population groups previously exposed to malaria. Lancet 1972; 1:512-515
21. Collins WE, Skinner JC, Jeffery GM: Studies on the persistence of malarial antibody response. Am J Epidemiol 1968; 87:592-598
22. Gauzzi M, Grazan S: A relapse of quartan malaria after 53 years latency. Trop Dis Bull 1964; 61:11-12
23. Besson P, Robert JF, Reviron J, Richard-Lenoble D, Gentilini M: [Two cases of transfusional malaria. Attempted prevention combining an indirect immunofluorescence test with clinical selection critera.] Rev Fr Transfus Immunohematol 1976; 19:369-373
24. Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ: Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion 2002; 42:1365-1372
25. Kitchen AD, Lowe PHJ, Lalloo K and Chrodimi PL: Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004; 87:150-155
26. Kitchen A, Mijovic, A. Hewitt P: Transfusion transmitted malaria - current donor selection guidelines are not sufficient. Vox Sang 2005; in press